1. Beyond Dendritic Cells: A Cellular Pharmacology Agenda for mRNA Cancer Vaccines in Hematologic Malignancies
Morabito F, Martino Ea, Bruzzese A, Amodio N, Caserta S, Lucia E, Et Al.
mRNA-based vaccines are emerging as a promising platform for cancer immunotherapy, including in hematologic malignancies. Current vaccine development has largely focused on antigen selection, mRNA engineering, lipid nanoparticle (LNP) formulation, and combination with established immunotherapies. However, increasing…
- T‐cell exhaustion
- cancer immunotherapy
- cellular pharmacology
- hematologic malignancies
- hepatocyte detargeting
- lipid nanoparticles
- mRNA vaccines
